Publicaciones en colaboración con investigadores/as de Hospital Virgen de la Arrixaca (21)

2024

  1. Epidemiological and clinical management aspects of pneumonias diagnosed in the emergency department in elderly patients in Spain: results of the EDEN-29 Study

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 42, Núm. 8, pp. 420-429

  2. Evolución clínica de los pacientes mayores diagnosticados de síncope en servicios de urgencias en España: resultados del estudio EDEN-17

    Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias, Vol. 36, Núm. 4, pp. 281-289

  3. Factors associated with discharge home in older patients admitted to emergency department observation units: Looking for a predictive scale

    Journal of Evaluation in Clinical Practice

  4. Impact of First Wave of COVID-19 Pandemic on Mortality at Emergency Department in Older Patients with COVID and Non-COVID Diagnoses

    Gerontology, Vol. 70, Núm. 4, pp. 379-389

  5. Impact of dementia on 30-, 180-, and 365-day mortality during the first pandemic wave in older adults seen in spanish emergency departments diagnosed with or without COVID-19

    Aging and Mental Health, Vol. 28, Núm. 8, pp. 1110-1118

  6. Short-term prognosis of polypharmacy in elderly patients treated in emergency departments: results from the EDEN project

    Therapeutic Advances in Drug Safety, Vol. 15

  7. Use of diagnostic tests in elderly patients consulting the emergency department. Analysis of the emergency department and elder needs cohort (EDEN-8)

    Australasian Emergency Care

2023

  1. Study EDEN-12: analysis of access to intensive care units of patients older than 65 years requiring emergency hospitalization

    Medicina Intensiva, Vol. 47, Núm. 11, pp. 638-647

2022

  1. Factors associated with lesion detection in colonoscopy among different indications

    United European Gastroenterology Journal, Vol. 10, Núm. 9, pp. 1008-1019

  2. Ischemic-hemorrhagic balance in diabetic and non-diabetic patients after acute coronary syndrome

    REC: CardioClinics, Vol. 57, Núm. 3, pp. 203-211

  3. Safety and Revisit Related to Discharge the Sixty-one Spanish Emergency Department Medical Centers Without Hospitalization in Patients with COVID-19 Pneumonia. A Prospective Cohort Study UMC-Pneumonia COVID-19

    Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion, Vol. 74, Núm. 3, pp. 135-146

  4. Sociodemographic characteristics, comorbidity, and baseline functional status of older patients treated in emergency departments during the COVID-19 pandemic and associations with mortality: an analysis based on the EDENCOVID cohort

    Emergencias, Vol. 34, Núm. 6, pp. 428-436

2021

  1. Frequency of five cardiovascular/hemostatic entities as primary manifestations of SARS-CoV-2 infection: Results of the UMC-19-S2

    International Journal of Cardiology, Vol. 330, pp. 268-272

  2. Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome

    European heart journal, Vol. 42, Núm. 33, pp. 3127-3142

  3. Ticagrelor versus prasugrel in acute coronary syndrome: sex-specific analysis from the RENAMI Registry

    Minerva cardiology and angiology, Vol. 69, Núm. 4, pp. 408-416

2020

  1. Variation in Colonoscopy Performance Measures According to Procedure Indication

    Clinical Gastroenterology and Hepatology, Vol. 18, Núm. 5, pp. 1216-1223.e2

2019

  1. Annual Incidence of Confirmed Stent Thrombosis and Clinical Predictors in Patients With ACS Treated With Ticagrelor or Prasugrel

    Revista Espanola de Cardiologia, Vol. 72, Núm. 4, pp. 298-304

  2. Correction to: Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI Registry (American Journal of Cardiovascular Drugs, (2019), 19, 4, (381-391), 10.1007/s40256-019-00339-3)

    American Journal of Cardiovascular Drugs

  3. Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI Registry

    American Journal of Cardiovascular Drugs, Vol. 19, Núm. 4, pp. 381-391

  4. Usefulness of the PARIS Score to Evaluate the Ischemic-hemorrhagic Net Benefit With Ticagrelor and Prasugrel After an Acute Coronary Syndrome

    Revista Espanola de Cardiologia, Vol. 72, Núm. 3, pp. 215-223